Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

ACRSACRS
Showing 7 of 26 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in ACLARIS THERAPEUTICS INC

ADAGE CAPITAL PARTNERS GP, L.L.C. holds 4.1M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $21.5M as of 2026-Q2. The position was increased (+5.2% shares). ACRS represents 0.0% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.

Current Value

$21.5M

Current Shares

4.1M

Total Value Change

-$2.3M

Total Shares Change

-5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.1M
+5.2%
$21.5M0.0%$5.29
30
2026-Q1
Increased
3.9M
+14.8%
$14.5M0.0%$3.04
32
2025-Q4
Decreased
3.4M
-36.1%
$10.1M0.0%$2.90
0
2025-Q3
Decreased
5.3M
-45.2%
$10M0.0%$1.92
0
2025-Q2
Unchanged
9.6M
0.0%
$13.7M0.0%$1.47
0
2025-Q1
Unchanged
9.6M
0.0%
$14.7M0.0%$1.59
0
2024-Q4
New
9.6M
-
$23.9M0.0%$2.48
40

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used